Impact of HDL oxidation by the myeloperoxidase system on sterol efflux by the ABCA1 pathway

Journal of Proteomics

Volumn 74, Issue 11, 2011, Pages 2289-2299

  Shao, Baohai ^a   Heinecke, Jay W ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

3 Chlorotyrosine; 3 Nitrotyrosine; Apolipoprotein A I; Biomarker; Coronary artery disease; Dysfunctional HDL

Indexed keywords

3 CHLOROTYROSINE; 3 NITROTYROSINE; ABC TRANSPORTER A1; APOLIPOPROTEIN A1; CHLORAMINE DERIVATIVE; EOSINOPHIL PEROXIDASE; HIGH DENSITY LIPOPROTEIN; HYPOCHLOROUS ACID; INDUCIBLE NITRIC OXIDE SYNTHASE; LOW DENSITY LIPOPROTEIN; LYSINE; METHIONINE; MYELOPEROXIDASE; PHENYLALANINE; SERUM AMYLOID A; TRYPTOPHAN; TYROSINE;

ACUTE PHASE RESPONSE; ANTIINFLAMMATORY ACTIVITY; ARTERY WALL; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; CELL PROLIFERATION; CHLORINATION; CHOLESTEROL TRANSPORT; CORONARY ARTERY DISEASE; CORONARY RISK; DISEASE MARKER; ENZYME RELEASE; EOSINOPHIL; HEART PROTECTION; HEMATOPOIETIC STEM CELL; HUMAN; LEUKOCYTOSIS; LIPID TRANSPORT; LIPOPROTEIN BLOOD LEVEL; LIPOPROTEIN METABOLISM; MACROPHAGE; MONOCYTE; NEUTROPHIL; NITRATION; NONHUMAN; OXIDATION; PHAGOCYTE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN MOTIF; PROTEIN STRUCTURE; REVIEW; TANDEM MASS SPECTROMETRY; TURBIDIMETRY;

AMINO ACID SEQUENCE; ANIMALS; ATP-BINDING CASSETTE TRANSPORTERS; HUMANS; LIPOPROTEINS, HDL; METABOLIC NETWORKS AND PATHWAYS; MODELS, BIOLOGICAL; OXIDATION-REDUCTION; PEROXIDASE; STEROLS;

EID: 80053410602     PISSN: 18743919     EISSN: 18767737     Source Type: Journal    
DOI: 10.1016/j.jprot.2011.04.001     Document Type: Review

References (90)

1. Cerutti P.A., Trump B.F. Inflammation and oxidative stress in carcinogenesis. Cancer Cells 1991, 3:1-7.
2. Stocker R., Keaney J.F. Role of oxidative modifications in atherosclerosis. Physiol Rev 2004, 84:1381-1478.
3. Ames B.N., Shigenaga M.K., Hagen T.M. Oxidants, antioxidants, and the degenerative diseases of aging. Proc Natl Acad Sci U S A 1993, 90:7915-7922.
4. Daugherty A., Dunn J.L., Rateri D.L., Heinecke J.W. Myeloperoxidase, a catalyst for lipoprotein oxidation, is expressed in human atherosclerotic lesions. J Clin Invest 1994, 94:437-444.
5. Heinecke J.W. Tyrosyl radical production by myeloperoxidase: a phagocyte pathway for lipid peroxidation and dityrosine cross-linking of proteins. Toxicology 2002, 177:11-22.
6. Brennan M.L., Anderson M.M., Shih D.M., Qu X.D., Wang X., Mehta A.C., et al. Increased atherosclerosis in myeloperoxidase-deficient mice. J Clin Invest 2001, 107:419-430.
7. Gaut J.P., Yeh G.C., Tran H.D., Byun J., Henderson J.P., Richter G.M., et al. Neutrophils employ the myeloperoxidase system to generate antimicrobial brominating and chlorinating oxidants during sepsis. Proc Natl Acad Sci U S A 2001, 98:11961-11966.
8. Klebanoff S.J. Iodination of bacteria: a bactericidal mechanism. J Exp Med 1967, 126:1063-1078.
9. Goldstein J.L., Ho Y.K., Basu S.K., Brown M.S. Binding site on macrophages that mediates uptake and degradation of acetylated low density lipoprotein, producing massive cholesterol deposition. Proc Natl Acad Sci U S A 1979, 76:333-337.
10. Steinberg D. Modified forms of low-density lipoprotein and atherosclerosis. J Intern Med 1993, 233:227-232.
11. Heinecke J.W. Oxidants and antioxidants in the pathogenesis of atherosclerosis: implications for the oxidized low density lipoprotein hypothesis. Atherosclerosis 1998, 141:1-15.
12. Heinecke J.W. Is the emperor wearing clothes? Clinical trials of vitamin E and the LDL oxidation hypothesis. Arterioscler Thromb Vasc Biol 2001, 21:1261-1264.
13. Oram J.F., Heinecke J.W. ATP-binding cassette transporter A1: a cell cholesterol exporter that protects against cardiovascular disease. Physiol Rev 2005, 85:1343-1372.
14. Tall A.R., Yvan-Charvet L., Terasaka N., Pagler T., Wang N. HDL, ABC transporters, and cholesterol efflux: implications for the treatment of atherosclerosis. Cell Metab 2008, 7:365-375.
15. Thomas M.J., Bhat S., Sorci-Thomas M.G. Three-dimensional models of HDL apoA-I: implications for its assembly and function. J Lipid Res 2008, 49:1875-1883.
16. Yvan-Charvet L., Wang N., Tall A.R. Role of HDL, ABCA1, and ABCG1 transporters in cholesterol efflux and immune responses. Arterioscler Thromb Vasc Biol 2010, 30:139-143.
17. Hurst J.K., Barrette W.C. Leukocytic oxygen activation and microbicidal oxidative toxins. Crit Rev Biochem Mol Biol 1989, 24:271-328.
18. Klebanoff S.J. Oxygen metabolism and the toxic properties of phagocytes. Ann Intern Med 1980, 93:480-489.
19. Henderson J.P. Myeloperoxidase and eosinophil peroxidase: phagocytosis and microbial killing. Heme peroxidases 1999, 349-385. John Wiley & Sons, Inc., New York. H.B. Dunford (Ed.).
20. Heinecke J.W. Pathways for oxidation of low density lipoprotein by myeloperoxidase: tyrosyl radical, reactive aldehydes, hypochlorous acid and molecular chlorine. Biofactors 1997, 6:145-155.
21. Domigan N.M., Charlton T.S., Duncan M.W., Winterbourn C.C., Kettle A.J. Chlorination of tyrosyl residues in peptides by myeloperoxidase and human neutrophils. J Biol Chem 1995, 270:16542-16548.
22. Hazen S.L., Hsu F.F., Mueller D.M., Crowley J.R., Heinecke J.W. Human neutrophils employ chlorine gas as an oxidant during phagocytosis. J Clin Invest 1996, 98:1283-1289.
23. Hazen S.L., Heinecke J.W. 3-Chlorotyrosine, a specific marker of myeloperoxidase-catalyzed oxidation, is markedly elevated in low density lipoprotein isolated from human atherosclerotic intima. J Clin Invest 1997, 99:2075-2081.
24. MacMicking J., Xie Q.W., Nathan C. Nitric oxide and macrophage function. Annu Rev Immunol 1997, 15:323-350.
25. Beckman J.S., Beckman T.W., Chen J., Marshall P.A., Freeman B.A. Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide. Proc Natl Acad Sci U S A 1990, 87:1620-1624.
26. Radi R., Peluffo G., Alvarez M.N., Naviliat M., Cayota A. Unraveling peroxynitrite formation in biological systems. Free Radic Biol Med 2001, 30:463-488.
27. Eiserich J.P., Hristova M., Cross C.E., Jones A.D., Freeman B.A., Halliwell B., et al. Formation of nitric oxide-derived inflammatory oxidants by myeloperoxidase in neutrophils. Nature 1998, 391:393-397.
28. Gaut J.P., Byun J., Tran H.D., Lauber W.M., Carroll J.A., Hotchkiss R.S., et al. Myeloperoxidase produces nitrating oxidants in vivo. J Clin Invest 2002, 109:1311-1319.
29. Klebanoff S.J. Reactive nitrogen intermediates and antimicrobial activity: role of nitrite. Free Radic Biol Med 1993, 14:351-360.
30. Goldstein J.L., Brown M.S. The LDL receptor. Arterioscler Thromb Vasc Biol 2009, 29:431-438.
31. Gordon T., Castelli W.P., Hjortland M.C., Kannel W.B., Dawber T.R. High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study. Am J Med 1977, 62:707-714.
32. Lewis G.F., Rader D.J. New insights into the regulation of HDL metabolism and reverse cholesterol transport. Circ Res 2005, 96:1221-1232.
33. Gordon D.J., Rifkind B.M. High-density lipoprotein-the clinical implications of recent studies. N Engl J Med 1989, 321:1311-1316.
34. Khera A.V., Cuchel M., de la Llera-Moya M., Rodrigues A., Burke M.F., Jafri K., et al. Cholesterol efflux capacity, high-density lipoprotein function, and atherosclerosis. N Engl J Med 2011, 364:127-135.
35. Yvan-Charvet L., Pagler T., Gautier E.L., Avagyan S., Siry R.L., Han S., et al. ATP-binding cassette transporters and HDL suppress hematopoietic stem cell proliferation. Science 2010, 328:1689-1693.
36. Lee J.Y., Parks J.S. ATP-binding cassette transporter AI and its role in HDL formation. Curr Opin Lipidol 2005, 16:19-25.
37. Rothblat G.H., Phillips M.C. High-density lipoprotein heterogeneity and function in reverse cholesterol transport. Curr Opin Lipidol 2010, 21:229-238.
38. Tall A.R., Costet P., Wang N. Regulation and mechanisms of macrophage cholesterol efflux. J Clin Invest 2002, 110:899-904.
39. Barter P.J., Nicholls S., Rye K.A., Anantharamaiah G.M., Navab M., Fogelman A.M. Antiinflammatory properties of HDL. Circ Res 2004, 95:764-772.
40. Suzuki M., Pritchard D.K., Becker L., Hoofnagle A.N., Tanimura N., Bammler T.K., et al. High-density lipoprotein suppresses the type I interferon response, a family of potent antiviral immunoregulators, in macrophages challenged with lipopolysaccharide. Circulation 2010, 122:1919-1927.
41. Goossens P., Gijbels M.J., Zernecke A., Eijgelaar W., Vergouwe M.N., van der Made I., et al. Myeloid type I interferon signaling promotes atherosclerosis by stimulating macrophage recruitment to lesions. Cell Metab 2010, 12:142-153.
42. Vaisar T., Pennathur S., Green P.S., Gharib S.A., Hoofnagle A.N., Cheung M.C., et al. Shotgun proteomics implicates protease inhibition and complement activation in the antiinflammatory properties of HDL. J Clin Invest 2007, 117:746-756.
43. Chait A., Han C.Y., Oram J.F., Heinecke J.W. Thematic review series: the immune system and atherogenesis. Lipoprotein-associated inflammatory proteins: markers or mediators of cardiovascular disease?. J Lipid Res 2005, 46:389-403.
44. Kontush A., Chapman M.J. Functionally defective high-density lipoprotein: a new therapeutic target at the crossroads of dyslipidemia, inflammation, and atherosclerosis. Pharmacol Rev 2006, 58:342-374.
45. de Beer M.C., Ji A., Jahangiri A., Vaughan A.M., de Beer F.C., van der Westhuyzen D.R., et al. ATP binding cassette G1-dependent cholesterol efflux during inflammation. J Lipid Res 2011, 52:345-353.
46. McGillicuddy F.C., de la Llera Moya M., Hinkle C.C., Joshi M.R., Chiquoine E.H., Billheimer J.T., et al. Inflammation impairs reverse cholesterol transport in vivo. Circulation 2009, 119:1135-1145.
47. van der Westhuyzen D.R., de Beer F.C., Webb N.R. HDL cholesterol transport during inflammation. Curr Opin Lipidol 2007, 18:147-151.
48. Shao B., Oda M.N., Oram J.F., Heinecke J.W. Myeloperoxidase: an oxidative pathway for generating dysfunctional high-density lipoprotein. Chem Res Toxicol 2010, 23:447-454.
49. Heinecke J. HDL and cardiovascular-disease risk-time for a new approach?. N Engl J Med 2011, 364:170-171.
50. Bergt C., Pennathur S., Fu X., Byun J., O'Brien K., McDonald T.O., et al. The myeloperoxidase product hypochlorous acid oxidizes HDL in the human artery wall and impairs ABCA1-dependent cholesterol transport. Proc Natl Acad Sci U S A 2004, 101:13032-13037.
51. Pennathur S., Bergt C., Shao B., Byun J., Kassim S.Y., Singh P., et al. Human atherosclerotic intima and blood of patients with established coronary artery disease contain high density lipoprotein damaged by reactive nitrogen species. J Biol Chem 2004, 279:42977-42983.
52. Zheng L., Nukuna B., Brennan M.L., Sun M., Goormastic M., Settle M., et al. Apolipoprotein A-I is a selective target for myeloperoxidase-catalyzed oxidation and functional impairment in subjects with cardiovascular disease. J Clin Invest 2004, 114:529-541.
53. Gotto A.M., Pownall H.J., Havel R.J. Introduction to the plasma lipoproteins. Methods Enzymol 1986, 128:3-41.
54. Davidson W.S., Thompson T.B. The structure of apolipoprotein A-I in high density lipoproteins. J Biol Chem 2007, 282:22249-22253.
55. Ryan R.O., Forte T.M., Oda M.N. Optimized bacterial expression of human apolipoprotein A-I. Protein Expr Purif 2003, 27:98-103.
56. Shao B., Oda M.N., Bergt C., Fu X., Green P.S., Brot N., et al. Myeloperoxidase impairs ABCA1-dependent cholesterol efflux through methionine oxidation and site-specific tyrosine chlorination of apolipoprotein A-I. J Biol Chem 2006, 281:9001-9004.
57. Heinecke J.W., Hsu F.F., Crowley J.R., Hazen S.L., Leeuwenburgh C., Mueller D.M., et al. Detecting oxidative modification of biomolecules with isotope dilution mass spectrometry: sensitive and quantitative assays for oxidized amino acids in proteins and tissues. Methods Enzymol 1999, 300:124-144.
58. Francis G.A., Knopp R.H., Oram J.F. Defective removal of cellular cholesterol and phospholipids by apolipoprotein A-I in Tangier disease. J Clin Invest 1995, 96:78-87.
59. Mendez A.J., Anantharamaiah G.M., Segrest J.P., Oram J.F. Synthetic amphipathic helical peptides that mimic apolipoprotein A-I in clearing cellular cholesterol. J Clin Invest 1994, 94:1698-1705.
60. Shao B., Bergt C., Fu X., Green P., Voss J.C., Oda M.N., et al. Tyrosine 192 in apolipoprotein A-I is the major site of nitration and chlorination by myeloperoxidase, but only chlorination markedly impairs ABCA1-dependent cholesterol transport. J Biol Chem 2005, 280:5983-5993.
61. Bergt C., Fu X., Huq N.P., Kao J., Heinecke J.W. Lysine residues direct the chlorination of tyrosines in YXXK motifs of apolipoprotein A-I when hypochlorous acid oxidizes high density lipoprotein. J Biol Chem 2004, 279:7856-7866.
62. Heinecke J.W., Baker L., Rosen H., Chait A. Superoxide-mediated modification of low density lipoprotein by arterial smooth muscle cells. J Clin Invest 1986, 77:757-761.
63. Shao B., Heinecke J.W. Using tandem mass spectrometry to quantify site-specific chlorination and nitration of proteins: model system studies with high-density lipoprotein oxidized by myeloperoxidase. Methods Enzymol 2008, 440:33-63.
64. Shao B., Tang C., Heinecke J.W., Oram J.F. Oxidation of apolipoprotein A-I by myeloperoxidase impairs the initial interactions with ABCA1 required for signaling and cholesterol export. J Lipid Res 2010, 51:1849-1858.
65. Bashtovyy D., Jones M.K., Anantharamaiah G.M., Segrest J.P. Sequence conservation of apolipoprotein A-I affords novel insights into HDL structure-function. J Lipid Res 2011, 52:435-450.
66. Oda M.N., Forte T.M., Ryan R.O., Voss J.C. The C-terminal domain of apolipoprotein A-I contains a lipid-sensitive conformational trigger. Nat Struct Biol 2003, 10:455-460.
67. Burgess J.W., Frank P.G., Franklin V., Liang P., McManus D.C., Desforges M., et al. Deletion of the C-terminal domain of apolipoprotein A-I impairs cell surface binding and lipid efflux in macrophage. Biochemistry 1999, 38:14524-14533.
68. Natarajan P., Forte T.M., Chu B., Phillips M.C., Oram J.F., Bielicki J.K. Identification of an apolipoprotein A-I structural element that mediates cellular cholesterol efflux and stabilizes ATP binding cassette transporter A1. J Biol Chem 2004, 279:24044-24052.
69. Vedhachalam C., Liu L., Nickel M., Dhanasekaran P., Anantharamaiah G.M., Lund-Katz S., et al. Influence of apoA-I structure on the ABCA1-mediated efflux of cellular lipids. J Biol Chem 2004, 279:49931-49939.
70. Hawkins C.L., Pattison D.I., Davies M.J. Hypochlorite-induced oxidation of amino acids, peptides and proteins. Amino Acids 2003, 25:259-274.
71. Panzenbock U., Stocker R. Formation of methionine sulfoxide-containing specific forms of oxidized high-density lipoproteins. Biochim Biophys Acta 2005, 1703:171-181.
72. Weissbach H., Resnick L., Brot N. Methionine sulfoxide reductases: history and cellular role in protecting against oxidative damage. Biochim Biophys Acta 2005, 1703:203-212.
73. Shao B., Oda M.N., Oram J.F., Heinecke J.W. Myeloperoxidase: an inflammatory enzyme for generating dysfunctional high density lipoprotein. Curr Opin Cardiol 2006, 21:322-328.
74. Panzenboeck U., Raitmayer S., Reicher H., Lindner H., Glatter O., Malle E., et al. Effects of reagent and enzymatically generated hypochlorite on physicochemical and metabolic properties of high density lipoproteins. J Biol Chem 1997, 272:29711-29720.
75. Peng D.Q., Brubaker G., Wu Z., Zheng L., Willard B., Kinter M., et al. Apolipoprotein A-I tryptophan substitution leads to resistance to myeloperoxidase-mediated loss of function. Arterioscler Thromb Vasc Biol 2008, 28:2063-2070.
76. Fitzgerald M.L., Morris A.L., Chroni A., Mendez A.J., Zannis V.I., Freeman M.W. ABCA1 and amphipathic apolipoproteins form high-affinity molecular complexes required for cholesterol efflux. J Lipid Res 2004, 45:287-294.
77. Wang N., Silver D.L., Costet P., Tall A.R. Specific binding of apoA-I, enhanced cholesterol efflux, and altered plasma membrane morphology in cells expressing ABC1. J Biol Chem 2000, 275:33053-33058.
78. Hassan H.H., Denis M., Lee D.Y., Iatan I., Nyholt D., Ruel I., et al. Identification of an ABCA1-dependent phospholipid-rich plasma membrane apolipoprotein A-I binding site for nascent HDL formation: implications for current models of HDL biogenesis. J Lipid Res 2007, 48:2428-2442.
79. Vaughan A.M., Tang C., Oram J.F. ABCA1 mutants reveal an interdependency between lipid export function, apoA-I binding activity, and Janus kinase 2 activation. J Lipid Res 2009, 50:285-292.
80. Vedhachalam C., Duong P.T., Nickel M., Nguyen D., Dhanasekaran P., Saito H., et al. Mechanism of ATP-binding cassette transporter A1-mediated cellular lipid efflux to apolipoprotein A-I and formation of high density lipoprotein particles. J Biol Chem 2007, 282:25123-25130.
81. Vedhachalam C., Ghering A.B., Davidson W.S., Lund-Katz S., Rothblat G.H., Phillips M.C. ABCA1-induced cell surface binding sites for apoA-I. Arterioscler Thromb Vasc Biol 2007, 27:1603-1609.
82. Zheng L., Settle M., Brubaker G., Schmitt D., Hazen S.L., Smith J.D., et al. Localization of nitration and chlorination sites on apolipoprotein A-I catalyzed by myeloperoxidase in human atheroma and associated oxidative impairment in ABCA1-dependent cholesterol efflux from macrophages. J Biol Chem 2005, 280:38-47.
83. Panzenbock U., Kritharides L., Raftery M., Rye K.A., Stocker R. Oxidation of methionine residues to methionine sulfoxides does not decrease potential antiatherogenic properties of apolipoprotein A-I. J Biol Chem 2000, 275:19536-19544.
84. Saito H., Dhanasekaran P., Nguyen D., Deridder E., Holvoet P., Lund-Katz S., et al. Alpha-helix formation is required for high affinity binding of human apolipoprotein A-I to lipids. J Biol Chem 2004, 279:20974-20981.
85. Aebersold R., Mann M. Mass spectrometry-based proteomics. Nature 2003, 422:198-207.
86. Mann M., Jensen O.N. Proteomic analysis of post-translational modifications. Nat Biotechnol 2003, 21:255-261.
87. Anderson L., Hunter C.L. Quantitative mass spectrometric multiple reaction monitoring assays for major plasma proteins. Mol Cell Proteomics 2006, 5:573-588.
88. Gerber S.A., Rush J., Stemman O., Kirschner M.W., Gygi S.P. Absolute quantification of proteins and phosphoproteins from cell lysates by tandem MS. Proc Natl Acad Sci U S A 2003, 100:6940-6945.
89. Shao B., Cavigiolio G., Brot N., Oda M.N., Heinecke J.W. Methionine oxidation impairs reverse cholesterol transport by apolipoprotein A-I. Proc Natl Acad Sci U S A 2008, 105:12224-12229.
90. Davidson W.S., Silva R.A. Apolipoprotein structural organization in high density lipoproteins: belts, bundles, hinges and hairpins. Curr Opin Lipidol 2005, 16:295-300.